Effect of cholesterol reduction by simvastatin on progression of coronary atherosclerosis: Design, baseline characteristics, and progress of the Multicenter Anti-Atheroma Study (MAAS)
- 30 June 1993
- journal article
- clinical trial
- Published by Elsevier in Controlled Clinical Trials
- Vol. 14 (3) , 209-228
- https://doi.org/10.1016/0197-2456(93)90004-w
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- The Value of Lowering Cholesterol after Myocardial InfarctionNew England Journal of Medicine, 1990
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- Progression of coronary atherosclerotic disease assessed by cinevideodensitometry: Relation to clinical risk factorsJournal of the American College of Cardiology, 1986
- Is Relationship Between Serum Cholesterol and Risk of Premature Death From Coronary Heart Disease Continuous and Graded?JAMA, 1986
- Diet, Lipoproteins, and the Progression of Coronary AtherosclerosisNew England Journal of Medicine, 1985
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJAMA, 1984
- Effect of lipid-lowering therapy on the progression of coronary atherosclerosis assessed by scheduled repetitive coronary arteriographyInternational Journal of Cardiology, 1982
- Use of combined diet and colestipol in long-term (7--7 1/2 years) treatment of patients with type II hyperlipoproteinemia.Circulation, 1979
- A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.Heart, 1978
- A Controlled Clinical Trial of a Diet High in Unsaturated Fat in Preventing Complications of AtherosclerosisCirculation, 1969